vs
Side-by-side financial comparison of Shutterstock, Inc. (SSTK) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.
Shutterstock, Inc. is the larger business by last-quarter revenue ($220.2M vs $158.6M, roughly 1.4× Stoke Therapeutics, Inc.). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs -7.3%, a 78.5% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs -12.0%). Stoke Therapeutics, Inc. produced more free cash flow last quarter ($131.7M vs $25.9M).
Shutterstock, Inc. is an American provider of stock photography, stock footage, stock music, and editing tools; it is headquartered in New York. Founded in 2002 by programmer and photographer Jon Oringer, Shutterstock maintains a library of around 200 million royalty-free stock photos, vector graphics, and illustrations, with around 10 million video clips and music tracks available for licensing. Originally a subscription site only, Shutterstock expanded beyond subscriptions into à la carte p...
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
SSTK vs STOK — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $220.2M | $158.6M |
| Net Profit | $-16.0M | $112.9M |
| Gross Margin | 55.8% | — |
| Operating Margin | -1.1% | 70.2% |
| Net Margin | -7.3% | 71.2% |
| Revenue YoY | -12.0% | 3661.1% |
| Net Profit YoY | -1021.0% | 528.0% |
| EPS (diluted) | $-0.47 | $1.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $220.2M | — | ||
| Q3 25 | $260.1M | — | ||
| Q2 25 | $267.0M | — | ||
| Q1 25 | $242.6M | $158.6M | ||
| Q4 24 | $250.3M | $22.6M | ||
| Q3 24 | $250.6M | — | ||
| Q2 24 | $220.1M | — | ||
| Q1 24 | $214.3M | — |
| Q4 25 | $-16.0M | — | ||
| Q3 25 | $13.4M | — | ||
| Q2 25 | $29.4M | — | ||
| Q1 25 | $18.7M | $112.9M | ||
| Q4 24 | $-1.4M | $-10.5M | ||
| Q3 24 | $17.6M | — | ||
| Q2 24 | $3.6M | — | ||
| Q1 24 | $16.1M | — |
| Q4 25 | 55.8% | — | ||
| Q3 25 | 60.6% | — | ||
| Q2 25 | 60.3% | — | ||
| Q1 25 | 58.4% | — | ||
| Q4 24 | 55.1% | — | ||
| Q3 24 | 58.3% | — | ||
| Q2 24 | 58.5% | — | ||
| Q1 24 | 58.8% | — |
| Q4 25 | -1.1% | — | ||
| Q3 25 | 12.5% | — | ||
| Q2 25 | 13.0% | — | ||
| Q1 25 | 4.2% | 70.2% | ||
| Q4 24 | 5.3% | -60.4% | ||
| Q3 24 | 7.2% | — | ||
| Q2 24 | 9.4% | — | ||
| Q1 24 | 7.8% | — |
| Q4 25 | -7.3% | — | ||
| Q3 25 | 5.1% | — | ||
| Q2 25 | 11.0% | — | ||
| Q1 25 | 7.7% | 71.2% | ||
| Q4 24 | -0.6% | -46.4% | ||
| Q3 24 | 7.0% | — | ||
| Q2 24 | 1.6% | — | ||
| Q1 24 | 7.5% | — |
| Q4 25 | $-0.47 | — | ||
| Q3 25 | $0.37 | — | ||
| Q2 25 | $0.82 | — | ||
| Q1 25 | $0.53 | $1.90 | ||
| Q4 24 | $-0.04 | $-0.15 | ||
| Q3 24 | $0.50 | — | ||
| Q2 24 | $0.10 | — | ||
| Q1 24 | $0.45 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $178.2M | $274.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $581.0M | $350.1M |
| Total Assets | $1.4B | $406.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $178.2M | — | ||
| Q3 25 | $165.5M | — | ||
| Q2 25 | $116.4M | — | ||
| Q1 25 | $112.2M | $274.8M | ||
| Q4 24 | $111.3M | $128.0M | ||
| Q3 24 | $131.4M | — | ||
| Q2 24 | $74.9M | — | ||
| Q1 24 | $71.8M | — |
| Q4 25 | $581.0M | — | ||
| Q3 25 | $594.4M | — | ||
| Q2 25 | $586.2M | — | ||
| Q1 25 | $547.2M | $350.1M | ||
| Q4 24 | $518.4M | $229.0M | ||
| Q3 24 | $522.9M | — | ||
| Q2 24 | $520.4M | — | ||
| Q1 24 | $541.3M | — |
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.3B | $406.9M | ||
| Q4 24 | $1.3B | $271.6M | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.0B | — | ||
| Q1 24 | $1.0B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $36.2M | $131.8M |
| Free Cash FlowOCF − Capex | $25.9M | $131.7M |
| FCF MarginFCF / Revenue | 11.8% | 83.0% |
| Capex IntensityCapex / Revenue | 4.7% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.17× |
| TTM Free Cash FlowTrailing 4 quarters | $123.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.2M | — | ||
| Q3 25 | $78.4M | — | ||
| Q2 25 | $26.8M | — | ||
| Q1 25 | $25.2M | $131.8M | ||
| Q4 24 | $8.0M | $-23.2M | ||
| Q3 24 | $-11.6M | — | ||
| Q2 24 | $28.0M | — | ||
| Q1 24 | $8.3M | — |
| Q4 25 | $25.9M | — | ||
| Q3 25 | $68.0M | — | ||
| Q2 25 | $15.5M | — | ||
| Q1 25 | $14.4M | $131.7M | ||
| Q4 24 | $-952.0K | $-23.2M | ||
| Q3 24 | $-26.3M | — | ||
| Q2 24 | $18.9M | — | ||
| Q1 24 | $-6.2M | — |
| Q4 25 | 11.8% | — | ||
| Q3 25 | 26.1% | — | ||
| Q2 25 | 5.8% | — | ||
| Q1 25 | 6.0% | 83.0% | ||
| Q4 24 | -0.4% | -102.7% | ||
| Q3 24 | -10.5% | — | ||
| Q2 24 | 8.6% | — | ||
| Q1 24 | -2.9% | — |
| Q4 25 | 4.7% | — | ||
| Q3 25 | 4.0% | — | ||
| Q2 25 | 4.2% | — | ||
| Q1 25 | 4.5% | 0.1% | ||
| Q4 24 | 3.6% | 0.2% | ||
| Q3 24 | 5.9% | — | ||
| Q2 24 | 4.1% | — | ||
| Q1 24 | 6.7% | — |
| Q4 25 | — | — | ||
| Q3 25 | 5.86× | — | ||
| Q2 25 | 0.91× | — | ||
| Q1 25 | 1.35× | 1.17× | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.66× | — | ||
| Q2 24 | 7.71× | — | ||
| Q1 24 | 0.51× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
